Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

Clinical trial NCT01549964 · TERMINATED

Trial details

NCT number: NCT01549964
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Glycemic Control

Start date: 2012-04-01
Primary completion: 2014-03-01
Enrollment: 916

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.